ingest

Merck Q3 2007 Earnings Call Transcript

It is interesting to note that as a consumer of Merck products, you describe the impact of VIOXX in terms of runrates and litigation costs. As an investor with Franklin Templeton I shudder thinking of those whose lives have been devastated by ingestion of Vioxx. Probably very few of the vicitms of your deceipt have very good run rates now that their hearts are shot. May God be merciful to your souls, I sure wouldn't be.